---
$id: https://graph.org.ai/products/commodity/51262004
$type: Product
source: UNSPSC
code: "51262004"
title: "Moxisylyte"
class: "51262000"
classTitle: "Adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Moxisylyte

**UNSPSC Code**: 51262004
**Class**: [Adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines](Adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C16H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PW8QYA7KI0, chemically known as phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester) but generally known as moxisylyte, which bears US NIH Compound Identifier 4260. European Medicines Agency schedules Moxisylyte in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09090MIG. The term MOXISYLYTE is an International Non-Proprietary Name. World Health Organization schedules moxisylyte in its Anatomical Therapeutic Chemical (ATC) Classification. MOXISYLYTE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule moxisylyte under HS 29221980 and SITC 51461. As of Q4 2014, MOXISYLYTE remains the US FDA Preferred Term for this commodity. Moxisylyte bears US NLM identifiers UMLS ID C0040108 and NCI Concept Code C87584. SMILES: O(C1C(C(C)C)CC(OC(=O)C)C(C1)C)CCN(C)C.

